143 related articles for article (PubMed ID: 9376990)
1. Anaemia of chronic disease in rheumatoid arthritis: in vivo effects of tumour necrosis factor alpha blockade.
Davis D; Charles PJ; Potter A; Feldmann M; Maini RN; Elliott MJ
Br J Rheumatol; 1997 Sep; 36(9):950-6. PubMed ID: 9376990
[TBL] [Abstract][Full Text] [Related]
2. R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritis.
Jongen-Lavrencic M; Peeters HR; Backx B; Touw IP; Vreugdenhil G; Swaak AJ
Rheumatol Int; 1994; 14(3):109-13. PubMed ID: 7839070
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between tumor necrosis factor alpha, interleukin-6 and erythropoietin in children's with chronic anemia and influence of recombinant human tumor necrosis factor alpha on erythropoietin gene expression].
Zhai XW; Wu Y; Gu XF; Lu FJ
Zhonghua Er Ke Za Zhi; 2004 Jan; 42(1):62-5. PubMed ID: 14990112
[TBL] [Abstract][Full Text] [Related]
4. [The correlation of cytokines TNF alpha, IFN-gamma, Epo with anemia in rheumatoid arthritis].
Zhu Y; Ye D; Huang Z
Zhonghua Xue Ye Xue Za Zhi; 2000 Nov; 21(11):587-90. PubMed ID: 11225250
[TBL] [Abstract][Full Text] [Related]
5. Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti-tumor necrosis factor-alpha antibody therapy.
Papadaki HA; Kritikos HD; Valatas V; Boumpas DT; Eliopoulos GD
Blood; 2002 Jul; 100(2):474-82. PubMed ID: 12091338
[TBL] [Abstract][Full Text] [Related]
6. The role of erythropoietin in the anaemia of chronic disease in rheumatoid arthritis.
Vreugdenhil G; Swaak AJ
Clin Rheumatol; 1990 Mar; 9(1):22-7. PubMed ID: 2185909
[TBL] [Abstract][Full Text] [Related]
7. Anemia in early rheumatoid arthritis is associated with interleukin 6-mediated bone marrow suppression, but has no effect on disease course or mortality.
Nikolaisen C; Figenschau Y; Nossent JC
J Rheumatol; 2008 Mar; 35(3):380-6. PubMed ID: 18260177
[TBL] [Abstract][Full Text] [Related]
8. Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic disease.
Jongen-Lavrencic M; Peeters HR; Wognum A; Vreugdenhil G; Breedveld FC; Swaak AJ
J Rheumatol; 1997 Aug; 24(8):1504-9. PubMed ID: 9263142
[TBL] [Abstract][Full Text] [Related]
9. Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trial.
Peeters HR; Jongen-Lavrencic M; Vreugdenhil G; Swaak AJ
Ann Rheum Dis; 1996 Oct; 55(10):739-44. PubMed ID: 8984939
[TBL] [Abstract][Full Text] [Related]
10. Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.
Smith MA; Knight SM; Maddison PJ; Smith JG
Ann Rheum Dis; 1992 Jun; 51(6):753-7. PubMed ID: 1616358
[TBL] [Abstract][Full Text] [Related]
11. Anaemia in rheumatoid arthritis: pathogenesis, diagnosis and treatment.
Vreugdenhil G; Swaak AJ
Rheumatol Int; 1990; 9(6):243-57. PubMed ID: 2180049
[TBL] [Abstract][Full Text] [Related]
12. Autologous blood transfusion with recombinant erythropoietin treatment in anaemic patients with rheumatoid arthritis.
Tanaka N; Ito K; Ishii S; Yamazaki I
Clin Rheumatol; 1999; 18(4):293-8. PubMed ID: 10468168
[TBL] [Abstract][Full Text] [Related]
13. [Pattern of blood levels of erythropoietin and proinflammatory cytokines in patients with anemia of chronic disorders secondary to infection].
Poveda Gómez F; Camacho Siles J; Quevedo Morales E; Fernández Zamorano A; Codoceo Alquinta R; Arnalich Fernández F; Sempere Alcocer M
An Med Interna; 2001 Jun; 18(6):298-304. PubMed ID: 11503575
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum transcobalamin levels in anaemia of rheumatoid arthritis: correlation with disease activity but not with serum tumour necrosis factor alpha and interleukin 6.
Vreugdenhil G; Lindemans J; van Eijk HG; Swaak AJ
J Intern Med; 1992 May; 231(5):547-50. PubMed ID: 1602292
[TBL] [Abstract][Full Text] [Related]
15. Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA.
Ohshima S; Mima T; Sasai M; Nishioka K; Shimizu M; Murata N; Yoshikawa H; Nakanishi K; Suemura M; McCloskey RV; Kishimoto T; Saeki Y
Cytokine; 2000 Mar; 12(3):281-8. PubMed ID: 10704256
[TBL] [Abstract][Full Text] [Related]
16. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2).
Elliott MJ; Woo P; Charles P; Long-Fox A; Woody JN; Maini RN
Br J Rheumatol; 1997 May; 36(5):589-93. PubMed ID: 9189062
[TBL] [Abstract][Full Text] [Related]
17. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis.
Elliott MJ; Maini RN; Feldmann M; Kalden JR; Antoni C; Smolen JS; Leeb B; Breedveld FC; Macfarlane JD; Bijl H
Lancet; 1994 Oct; 344(8930):1105-10. PubMed ID: 7934491
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with a fully human anti-tumour necrosis factor alpha monoclonal antibody on the local and systemic homeostasis of interleukin 1 and TNFalpha in patients with rheumatoid arthritis.
Barrera P; Joosten LA; den Broeder AA; van de Putte LB; van Riel PL; van den Berg WB
Ann Rheum Dis; 2001 Jul; 60(7):660-9. PubMed ID: 11406520
[TBL] [Abstract][Full Text] [Related]
19. Anaemia of chronic disease in rheumatoid arthritis. Raised serum interleukin-6 (IL-6) levels and effects of IL-6 and anti-IL-6 on in vitro erythropoiesis.
Vreugdenhil G; Löwenberg B; van Eijk HG; Swaak AJ
Rheumatol Int; 1990; 10(3):127-30. PubMed ID: 2392639
[TBL] [Abstract][Full Text] [Related]
20. In vivo blockade of tumor necrosis factor-alpha in patients with rheumatoid arthritis: longterm effects after repeated infusion of chimeric monoclonal antibody cA2.
Lorenz HM; Grünke M; Hieronymus T; Antoni C; Nüsslein H; Schaible TF; Manger B; Kalden JR
J Rheumatol; 2000 Feb; 27(2):304-10. PubMed ID: 10685789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
